首页
> 多重解析
多重解析地址选择页面
题 名: | CyCAR标准与RECIST标准在一线应用贝伐珠单抗治疗晚期非鳞非小细胞肺癌疗效评价中的比较 | ||||||||||
第一作者: | Liu Yangyang | ||||||||||
期刊名称: | 山西医药杂志 | 出版年 | 2021 | 卷 | 50 | 期 | 20 | ||||
Title: | Comparison of CyCAR standard and RECIST standard in the evaluation of efficacy of bevacizumab in the first-line treatment of advanced non squamous NSCLC | ||||||||||
First author:: | Liu Yangyang | ||||||||||
Journal: | SHANXI MEDICAL JOURNAL | ||||||||||
Year | 2021 | Volume | 50 | Issue | 20 | ||||||
doi: | 10.3969/j.issn.0253-9926.2021.20.004 | ||||||||||
|
|||||||||||
请任选一个链接找到文章全文: | |||||||||||
万方医学网 | |||||||||||
万方知识服务平台 |